Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age < 65 with Type 2 Diabetes and Heart Failure with Reduced Ejection Fraction: A Cost –Benefit Analysis

Source: ClinicoEconomics and Outcomes Research - Category: Health Management Tags: ClinicoEconomics and Outcomes Research Source Type: research